BioNTech Inc. - BNTX Market Valuation
BioNTech SE (BNTX) is minimizing risks by adapting mRNA technologies to combat autoimmune pathologies and cancer. The company is currently transforming its portfolio by implementing breakthrough standards for individualized tumor therapy. Business success relies on R&D efficiency and capital burn, which constitutes 21.69. Serving as an assessment tool, this value chart on GURU.Markets allows for tracking the impact of clinical trials and M&A deals on the issuer's capitalization.
Comprehensive metric breakdowns and analytics for BioNTech Pharma (BNTX)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital BioNTech SE|BNTX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital BioNTech SE|BNTX - Company Aggregate Debts|Debt to Book Capitalization Ratio BioNTech Pharma|BNTX - Company Long-Term Loans and Borrowings|Company Short-Term Debt BioNTech|Quick Ratio biontech.de
- net income and valuation multiples indicators:
BNTX - Net Profit|Future Profit BioNTech SE|BNTX - Company Value to Net Income|Forward P/E Multiple BioNTech Group|BNTX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioNTech Pharma|BNTX - Operating profit before deduction of amortization|Earnings per share for the last twelve months BioNTech|BNTX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months biontech.de|BNTX - Earnings growth in current year|Net earnings per share growth forecast for next year BioNTech SE
Fundamental company analysis:BNTX (BioNTech)
Market capitalization is calculated as the product of the current share price and the total number of shares outstanding, reflecting the aggregate value of the business in real time. For BioNTech SE (BNTX), this metric measures market confidence in the potential of mRNA technologies, where future pricing power in the development of cancer treatments directly determines the market capitalization dynamics of the issuer.
Key competitors
Market Value argenx ARGX|ABVX: Market Capitalization|ADMA: Market Valuation|Protagonist Corp - Market Value|IMVT (Immunovant, Inc.) - Market Valuation|Market Capitalization KNSA|Market Value Grifols|Adaptive Biotech - Market Valuation|Market Capitalization CLDX|AUPH (Aurinia Corp) - Market Value|Market Capitalization BCRX (BioCryst)|Market Capitalization veratx.com VERA|DNTH - Market Value|Market Value PHVS (Pharvaris NV)|AbCellera (ABCL) - Market Value|Market Valuation Tourmaline|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|ACRS: Market Value|KYTX: Market Capitalization|TLSA - Market Capitalization|Market Value Cabaletta Bio|Market Value Ventyx Biosciences Inc. VTYX|Market Value Theratechnologies Inc (THTX)|Avalo Therapeutics Inc - Market Capitalization|Eledon Pharmaceuticals - Market Valuation|Market Value AGEN (agenusbio.com)|Climb Bio - Market Capitalization|Market Value zurabio.com|ATYR: Market Capitalization|Market Valuation Adagene Inc.|IMA (ImageneBio) - Market Capitalization|STTK: Market Value|Market Valuation EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Market Value|Market Value Immunic IMUX|Market Capitalization Atara Biotherapeutics, Inc. (ATRA)|InflaRx GmbH - Market Capitalization|Market Value x4pharma.com|ACET: Market Capitalization|CELU (Celularity) - Market Value|Market Value INmune Bio Corp|Market Capitalization BRNS (Barinthus Biotherapeutics Corp)|Market Valuation KZR (Kezar Life Sciences)|Market Value SABS|Akari Therapeutics Plc - Market Valuation|ENLV: Market Capitalization|QTTB - Market Value|Market Valuation GOVX|EDSA: Market Capitalization|ibioinc.com - Market Value|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Capitalization XTL Biopharmaceuticals Ltd|Market Value Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - Market Value|Market Value Aptevo Therapeutics Inc. APVO|AIM - Market Valuation|Aditxt Corp - Market Capitalization|GRI - Market Capitalization|XRTX (XORTX) - Market Valuation|Vyome Therapeutics - Market Value|REVB (Revelation Biosciences) - Market Capitalization|indaptusrx.com (INDP) - Market Capitalization|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|Market Valuation calcimedica.com CALI|Market Value Affimed N.V. AFMD|ALLK - Market Valuation|HOOK: Market Valuation|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Capitalization OCEA|TCBP (TC BioPharm (Holdings) PLC) - Market Capitalization|Market Value Third Harmonic Bio Inc THRD
